EUR 0.23
(22.34%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 1.82 Million EUR | 47.48% |
2022 | 1.23 Million EUR | -16.58% |
2021 | 1.48 Million EUR | 99.06% |
2020 | 744 Thousand EUR | -73.28% |
2019 | 2.78 Million EUR | 43.56% |
2018 | 1.93 Million EUR | -31.33% |
2017 | 2.82 Million EUR | 43.0% |
2016 | 1.97 Million EUR | 23.64% |
2015 | 1.59 Million EUR | 94.89% |
2014 | 819.67 Thousand EUR | 971.52% |
2013 | 76.49 Thousand EUR | 2549800.0% |
2012 | 3.00 EUR | -100.0% |
2011 | 937.42 Thousand EUR | 340.19% |
2010 | 212.96 Thousand EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 442 Thousand EUR | 0.0% |
2023 Q2 | 981 Thousand EUR | 0.0% |
2023 Q4 | 2.93 Million EUR | 0.0% |
2023 FY | 1.82 Million EUR | 47.48% |
2022 Q2 | 346.5 Thousand EUR | 0.0% |
2022 FY | 1.23 Million EUR | -16.58% |
2022 Q4 | 885.45 Thousand EUR | 0.0% |
2021 FY | 1.48 Million EUR | 99.06% |
2021 Q2 | 884.88 Thousand EUR | 0.0% |
2021 Q4 | 596 Thousand EUR | 0.0% |
2020 Q2 | 167 Thousand EUR | 0.0% |
2020 Q4 | 577 Thousand EUR | 0.0% |
2020 FY | 744 Thousand EUR | -73.28% |
2019 Q2 | 963 Thousand EUR | 0.0% |
2019 Q4 | 1.82 Million EUR | 0.0% |
2019 FY | 2.78 Million EUR | 43.56% |
2018 Q4 | 1.07 Million EUR | 0.0% |
2018 Q2 | 865.96 Thousand EUR | 0.0% |
2018 FY | 1.93 Million EUR | -31.33% |
2017 Q2 | 797.04 Thousand EUR | 0.0% |
2017 Q4 | 2.02 Million EUR | 0.0% |
2017 FY | 2.82 Million EUR | 43.0% |
2016 Q4 | 1.45 Million EUR | 0.0% |
2016 FY | 1.97 Million EUR | 23.64% |
2016 Q2 | 523.07 Thousand EUR | 0.0% |
2015 Q2 | 55.93 Thousand EUR | 0.0% |
2015 Q4 | 1.54 Million EUR | 0.0% |
2015 FY | 1.59 Million EUR | 94.89% |
2014 FY | 819.67 Thousand EUR | 971.52% |
2014 Q4 | 324.92 Thousand EUR | 0.0% |
2014 Q2 | 494.75 Thousand EUR | 0.0% |
2013 Q3 | 19.12 Thousand EUR | -58.45% |
2013 Q4 | 30.47 Thousand EUR | 59.36% |
2013 FY | 76.49 Thousand EUR | 2549800.0% |
2013 Q2 | 46.02 Thousand EUR | 0.0% |
2012 FY | 3.00 EUR | -100.0% |
2012 Q4 | 19.12 Thousand EUR | 2549766.67% |
2012 Q1 | 0.75 EUR | 0.0% |
2012 Q2 | 0.75 EUR | 0.0% |
2012 Q3 | 0.75 EUR | 0.0% |
2011 Q3 | 234.35 Thousand EUR | 0.0% |
2011 FY | 937.42 Thousand EUR | 340.19% |
2011 Q1 | 234.35 Thousand EUR | 0.0% |
2011 Q2 | 234.35 Thousand EUR | 0.0% |
2011 Q4 | 0.75 EUR | -100.0% |
2010 Q3 | 53.24 Thousand EUR | 0.0% |
2010 Q2 | 53.24 Thousand EUR | 0.0% |
2010 Q1 | 53.24 Thousand EUR | 0.0% |
2010 FY | 212.96 Thousand EUR | 0.0% |
2010 Q4 | 234.35 Thousand EUR | 340.19% |
2009 Q4 | 53.24 Thousand EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Affluent Medical SA | 1.22 Million EUR | -48.874% |
Bluelinea Société Anonyme | 9826.00 EUR | -18444.891% |
Carmat SA | 2.84 Million EUR | 36.018% |
Diagnostic Medical Systems S.A. | 42.15 Million EUR | 95.677% |
Euromedis Groupe | 37.42 Million EUR | 95.131% |
Eurobio Scientific Société anonyme | 130.64 Million EUR | 98.605% |
Ikonisys S.A. | 448.55 Thousand EUR | -306.241% |
Implanet S.A. | 7.44 Million EUR | 75.531% |
Median Technologies SA | 22.22 Million EUR | 91.801% |
SpineGuard SA | 4.31 Million EUR | 57.749% |
Euroapi S.A. | 1.01 Billion EUR | 99.821% |
Guerbet SA | 785.69 Million EUR | 99.768% |